The Business Times
business-time-50

Singapore pharmaceuticals

Companies & Markets

Competition watchdog seeks public feedback on Zuellig Pharma-Eli Lilly deal

Singapore can excel through investment and reinvestment to ensure continued innovation.
Opinion & Features
BRUNCH

Forget chasing the next Pfizer: Singapore’s biotech future lies in innovation, not giants

Factory output grew across the board in October, except for general manufacturing.
Singapore

Singapore’s October factory output records highest jump in 15 years, up 29.1% on pharma surge

The speciality pharmaceutical and nutraceutical company will use S$2 million of the proceeds to finance expenses linked to its expansion into the US.
Companies & Markets

iX Biopharma raises gross proceeds of S$6.7 million from placement

iX Biopharma has proposed a placement of new shares in the company at S$0.10 apiece.
Companies & Markets

iX Biopharma proposes placement to raise gross proceeds of at least S$5 million as it eyes US expansion

A strategic tie-up with a US company could lead to the monetisation of 22 drugs under development by September 2026, iX Biopharma said.
Companies & Markets

iX Biopharma shares jump 35% on potential US, Australia listing plans

Singapore mainly exports active pharmaceutical ingredients to the US, instead of finished products such as tablets and capsules.
Singapore

Singapore-based pharma companies waiting for confirmation of US tariff exemptions: MTI

Pharmaceutical exports to the US account for about S$4 billion of the Republic’s exports to the country, says Deputy Prime Minister Gan Kim Yong.
Singapore

New US pharmaceutical tariffs may have ‘no immediate impact’ on drugmakers: DPM Gan

Less-than-favourable valuations for biopharma companies may be a key reason behind the lack of such companies listing on the SGX.
Singapore

The biopharma scene in Singapore is vibrant, but few make it to SGX

Pharmaceutical firms that have broken ground on US facilities will receive exemptions.
Singapore

Trump’s pharma tariffs put Singapore at ‘greatest risk’ among major exporters if no exemptions granted: economists

Latest T-bills Treasury Bills Results & Interest NewsLatest SSB Singapore Savings Bonds NewsLatest COE Certificate of Entitlement News
Latest Johor-Singapore SEZ NewsLatest BTO Build To Order & Sales of Balance NewsLatest STI Straits Times Index NewsLatest SGX Dividends, Share Price NewsLatest Bonds Market NewsLatest Singapore Stocks To Buy NewsLatest Singapore Economy News
View More